Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
VIVK · 10-Q filed August 19, 2026

VIVK earnings analysis

What we found in VIVK's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

The provided 10-Q extract does not include the income statement, balance sheet, cash flow statement, segment disclosures, or current-quarter revenue and EPS, so those metrics cannot be assessed from the filing text supplied. The filing nevertheless highlights continued financial and reporting pressure: disclosure controls were ineffective as of June 30, 2026, material weaknesses remained unresolved, and significant debt obligations extend into October 2026 and beyond. Financing and debt conversions provided capital and reduced obligations, but the $12.0 million May financing and potential $100 million SEPA also create meaningful dilution risk. The filing states that there were no material changes to previously disclosed risk factors.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

$12 million financing completed
The May 2026 financing provided up to $12.0 million of gross proceeds before fees and expenses, with $6.0 million received at the May 8 closing and an additional $6.0 million received at the July 16 closing. Management said proceeds would fund working capital, debt reduction, and general corporate purposes.
Debt reduced through note conversions
Lenders converted $1,037,025 of outstanding notes into 104,501 common shares between June 4 and June 5, 2026, and converted an additional $1,628,113.78 into 214,522 shares between June 4 and June 17, 2026.
Nasdaq relisting achieved
Nasdaq determined the company was compliant with the Minimum Bid Price Requirement, and trading resumed on April 27, 2026. The company remains subject to a Mandatory Panel Monitor for one year from the April 23, 2026 letter.
Additional equity capital available
The company entered into a standby equity purchase agreement allowing potential purchases of up to $100 million of common stock over 36 months, subject to volume, registration, pricing, and ownership limitations.
Capital structure actions support listing
The company effected a 1-for-20 reverse stock split on July 17, 2026, following an earlier 1-for-200 reverse split on March 24, 2026, addressing share-price and listing compliance requirements.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Material weaknesses remain unresolved
Management and the CFO concluded that disclosure controls were not effective as of June 30, 2026 because of material weaknesses tied to insufficient accounting personnel, segregation-of-duties deficiencies, and inadequate review controls. Management stated the weaknesses had not been fully remediated as of June 30, 2026.
Near-term debt and default risk
The company has significant near-term debt obligations, including Cedarview notes with principal amounts of $3,000,000 and $3,670,160.77 that were extended only to October 31, 2026. The May 2026 Notes have aggregate principal of $15.0 million and contain default provisions that may accelerate amounts due.
Substantial equity dilution exposure
The SEPA permits up to $100 million of equity purchases over 36 months, and the company must register 270,270,271 shares issuable under the agreement. Shares are generally sold at a discount to prevailing market prices, creating substantial potential dilution and financing-price pressure.
Guidance

What they said about what is next.

The provided 10-Q text contains no quantitative revenue or EPS outlook and does not disclose a change to prior guidance. No numeric guidance was provided.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 20, 2026
Vivakor reported Q4 2026 results with significant upswing in revenue to $21M, reflecting a 112.8% rise compared to the previous quarter and marked improvement in gross margin to 112.8%. However, the company posted a…
10-K · April 15, 2026
Vivakor presents an integrated midstream strategy spanning transportation, terminaling, marketing and a remediation business expected to begin operations in Q1 2026. The company expanded scale via material acquisitions…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing VIVK makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever